Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib pharmacogenetics and clearance study
NL-OMON32880Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sunitinib in cancer, sponsored by Amsterdam University Medical Center. Primary endpoint: Correlation between ABCB1 polymorphisms and sunitinib clearance at steady state. Planned start Oct 2008; status: not yet recruiting.
02
Drugs
sunitinib
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON32880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32880.